This white paper, developed with insights from industry leaders, explores how digital transformation is reshaping pharmaceutical and chemical R&D. It outlines key drivers such as rising R&D costs, competitive pressure, data complexity, and the need for faster decision-making. Advanced analytics, machine learning, and cloud-based platforms enable organizations to optimize clinical trials, improve data quality, and accelerate innovation across discovery and development. The paper emphasizes executive sponsorship, robust data governance, and scalable infrastructure as critical success factors. Case examples highlight benefits such as reduced time to market, improved experiment quality, and enhanced collaboration. The document positions digital innovation as an essential enabler of sustainable

Join for free to read